Primary Immunodeficiencies: Pathogenetic Advances, Diagnostic and Management Challenges
This Special issue focuses of the most relevant advances in the field of inborn errors of immunity. Indeed, as immunology is rapidly progressing, with the constant discovery of new disease entities and the better characterization of molecular mechanisms and targeted therapies, a continuous update is...
Saved in:
Other Authors: | , |
---|---|
Format: | Electronic Book Chapter |
Language: | English |
Published: |
Basel
MDPI - Multidisciplinary Digital Publishing Institute
2023
|
Subjects: | |
Online Access: | DOAB: download the publication DOAB: description of the publication |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000naaaa2200000uu 4500 | ||
---|---|---|---|
001 | doab_20_500_12854_112528 | ||
005 | 20230808 | ||
003 | oapen | ||
006 | m o d | ||
007 | cr|mn|---annan | ||
008 | 20230808s2023 xx |||||o ||| 0|eng d | ||
020 | |a books978-3-0365-8309-9 | ||
020 | |a 9783036583082 | ||
020 | |a 9783036583099 | ||
040 | |a oapen |c oapen | ||
024 | 7 | |a 10.3390/books978-3-0365-8309-9 |c doi | |
041 | 0 | |a eng | |
042 | |a dc | ||
072 | 7 | |a TB |2 bicssc | |
072 | 7 | |a TCB |2 bicssc | |
100 | 1 | |a Consolini, Rita |4 edt | |
700 | 1 | |a Costagliola, Giorgio |4 edt | |
700 | 1 | |a Consolini, Rita |4 oth | |
700 | 1 | |a Costagliola, Giorgio |4 oth | |
245 | 1 | 0 | |a Primary Immunodeficiencies: Pathogenetic Advances, Diagnostic and Management Challenges |
260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2023 | ||
300 | |a 1 electronic resource (228 p.) | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
520 | |a This Special issue focuses of the most relevant advances in the field of inborn errors of immunity. Indeed, as immunology is rapidly progressing, with the constant discovery of new disease entities and the better characterization of molecular mechanisms and targeted therapies, a continuous update is mandatory for clinician and researchers. In this Issue, the non-infectious manifestations of inborn errors of immunity (such as autoimmunity, atopy, and lymphoproliferation) are deeply discussed, as well as the impact of the novel genetic sequencing techniques in the diagnostic approach. Moreover, some well-known disorders, including common variable immunodeficiency, are extensively reviewed and revisited in a modern way. Also, diseases of recent description, including some disorders of immune dysregulation and inborn errors of immunity associated with syndromes, are described. Finally, some of the papers of this Special Issue focus in a detailed way the molecular mechanisms leading to immunodeficiency and immune dysregulation, also opening the way for further clinical and preclinical studies. As the expanding availability of immunological and genetic testing offers the opportunity to identify new disease entities and elucidate the function of new genes involved in the development and regulation of the immune response, we aim to present the most relevant innovations in this delicate field. | ||
540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
546 | |a English | ||
650 | 7 | |a Technology: general issues |2 bicssc | |
650 | 7 | |a Biotechnology |2 bicssc | |
653 | |a B cell maturation | ||
653 | |a CD4+ cells | ||
653 | |a T cell maturation | ||
653 | |a primary immune deficiency | ||
653 | |a autoimmunity | ||
653 | |a connective tissue diseases | ||
653 | |a atopic diseases | ||
653 | |a atopy | ||
653 | |a allergy | ||
653 | |a selective IgA deficiency | ||
653 | |a primary immunodeficiency | ||
653 | |a autoimmune diseases | ||
653 | |a Immunoglobulin E | ||
653 | |a Immunoglobulin deficiency | ||
653 | |a infections | ||
653 | |a malignancy | ||
653 | |a 22q11.2 deletion syndrome | ||
653 | |a activated phosphoinositide 3-kinase d syndrome | ||
653 | |a common variable immunodeficiency | ||
653 | |a complement deficiency | ||
653 | |a CTLA-4 | ||
653 | |a Immune dysregulation | ||
653 | |a LRBA | ||
653 | |a severe combined immunodeficiency | ||
653 | |a X-linked agammaglobulinemia | ||
653 | |a anti-SARS-CoV-2 antibodies | ||
653 | |a COVID-19 | ||
653 | |a SARS-CoV-2 | ||
653 | |a PIMS-TS | ||
653 | |a Foxp3 | ||
653 | |a IPEX | ||
653 | |a CVID | ||
653 | |a primary immunodeficiencies | ||
653 | |a epigenetics | ||
653 | |a DNA methylation | ||
653 | |a inborn errors of immunity | ||
653 | |a DiGeorge syndrome | ||
653 | |a 22q11.2 deletion | ||
653 | |a thymic output | ||
653 | |a dendritic cells | ||
653 | |a immunodeficiency | ||
653 | |a copy number variations | ||
653 | |a array-CGH | ||
653 | |a IKZF1 | ||
653 | |a IKAROS | ||
653 | |a de novo mutation | ||
653 | |a R162Q | ||
653 | |a immune response | ||
653 | |a heterologous vaccine | ||
653 | |a humoral response | ||
653 | |a T-cell response | ||
653 | |a autoimmune lymphoproliferative syndrome | ||
653 | |a lymphoproliferation | ||
653 | |a gastrointestinal infections | ||
653 | |a Giardia | ||
653 | |a giardiasis | ||
653 | |a refractory | ||
653 | |a treatment | ||
653 | |a immunology | ||
653 | |a immunogenetic | ||
653 | |a eosinophilic gastrointestinal disorders | ||
653 | |a eosinophilic esophagitis | ||
653 | |a unclassified primary antibody deficiency | ||
653 | |a primary antibody deficiency | ||
653 | |a transient hypogammaglobulinemia of infancy | ||
653 | |a children | ||
653 | |a TNFRSF13B mutations | ||
653 | |a isolated IgM deficiency | ||
653 | |a n/a | ||
856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/7654 |7 0 |z DOAB: download the publication |
856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/112528 |7 0 |z DOAB: description of the publication |